Elsevier

Journal of Hepatology

Volume 49, Issue 4, October 2008, Pages 600-607
Journal of Hepatology

Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: A systematic review

https://doi.org/10.1016/j.jhep.2008.06.012Get rights and content

Background/Aims

To perform a systematic review of the studies addressing the association between non-alcoholic fatty liver disease (NAFLD) and carotid intima-media thickness (IMT).

Methods

Literature searches identified seven studies that met inclusion criteria: population-based or hospital-based case-control studies about the relation between NAFLD and carotid IMT, in which information on number of subjects in controls and NAFLD patients, and data to evaluate carotid IMT and carotid plaques (measured by carotid ultrasound) could be extracted.

Results

From a total of 3497 subjects (1427 patients and 2070 controls), we found a significant association between NAFLD and carotid IMT either in fixed (D: 0.51, 95% CI: 0.44–0.58, p < 1 × 10−8) or random models (D: 1.44, CI: 95% 0.63–2.24, p < 0.0006). Meta-regression analysis showed that mean differences in alanine aminotransferase and γ-GT were strongly correlated with those in IMT (p < 0.00006 and 0.004, respectively). In addition, 5 reports including 3212 subjects showed that carotid plaques were more frequently observed in NAFLD patients in comparison with controls, fixed model (p < 1 × 10−10), OR: 1.97 95% CI: 1.67–2.32 and random model p < 0.0002, OR: 3.13, 95% CI: 1.75–5.58.

Conclusions

Routine measurement of carotid IMT might be implemented in NAFLD patients, as they carry an increase of 13% of carotid IMT.

Introduction

The prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing worldwide because of the rise of obesity and type 2 diabetes prevalence [1]. NAFLD is present in 10–24% of the general population in various countries [2] and is closely related to insulin resistance and markers of oxidative stress and endothelial dysfunction [3], [4]. In fact, NAFLD is considered the hepatic manifestation of the metabolic syndrome (MS) [3], [5].

People with metabolic syndrome are at risk for cardiovascular disease, including coronary heart disease and stroke [6]. The importance of NAFLD and its relationship with MS is now increasingly recognized as recent data suggest that NAFLD is linked to increased cardiovascular risk independently of the broad spectrum of risk factors of MS [7]. Indeed, it is hypothesized that NAFLD is not merely a marker of cardiovascular disease but may also be involved in its pathogenesis [8].

Various non-invasive markers of early arterial wall alteration are currently available, such as arterial wall thickening and stiffening, endothelial dysfunction and coronary artery calcification [9]. Of them, non-invasive assessment of carotid intima-media thickness (IMT) by high-resolution carotid B-mode ultrasonography (US) is widely used as a proxy end point for cardiovascular disease [10]. In addition, carotid US allows the evaluation – in a simple, safe and reproducible way – of lumen diameter, intima-media thickness, and the presence and extent of carotid plaques.

Recent studies have shown that NAFLD patients have significantly greater carotid IMT than age and sex-matched patients without NAFLD, independently of the classical risk factors of the metabolic syndrome. However, some degree of variability about the mean carotid IMT values’ can be observed among all the published reports that result in a difficult evaluation of the magnitude of the observation. For instance, among the different studies, mean carotid IMT values in NAFLD patients range from 0.64 ± 0.10 mm to 1.24 ± 0.13 mm. The importance of this is to decide if further recommendations with regard to carotid atherosclerosis screening should be implemented in all NAFLD patients, as currently available epidemiological data indicate that a value of carotid IMT at or above 1 mm at any age is associated with a significantly increased risk of myocardial infarction and/or cerebrovascular disease [11].

In view of the evidence mentioned above, our primary purpose was to estimate from the available literature, the strength of the increased carotid IMT and carotid atherosclerosis observed in NAFLD patients. In addition, we systematically evaluated the study characteristics that could be responsible for the association.

Section snippets

Data sources and study selection

For the electronic searches, published studies were found through PubMed at the National Library of Medicine (http://ncbi.nlm.nih.gov/entrez/query) and in Medline databases for the query “(fatty liver or hepatic steatosis or non-alcoholic fatty liver disease) and (intima-media thickness, carotid artery, carotid plaque, cardiovascular disease and atherosclerosis)”. In addition, the references of the articles were checked and the PubMed link ‘related articles’ was used to identify additional

Results

We evaluated seven studies that met the selection criteria and that were identified using the search strategy described in Appendix Fig. A1. Studies characteristics are shown in Table 1. Data on one further study was unavailable because in the paper the authors did not disclose the raw data; the authors were contacted but they were unable to provide the data in the required format for evaluation [16]. In addition, the patients included in this study have fatty liver of unspecified aetiology.

Discussion

Recent epidemiological studies suggested an increased incidence of major cardiovascular events in patients with ultrasound-diagnosed NAFLD independent of traditional risk factors and components of the metabolic syndrome [7], [8], [24]. Moreover, the 14-year risk of cardiovascular mortality was doubled in 129 patients with biopsy-proven NAFLD compared with that of the reference population [25].

A strong association between NAFLD and endothelial dysfunction as measured by brachial artery

References (35)

  • H.M. Lakka et al.

    The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men

    JAMA

    (2002)
  • G. Targher et al.

    Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients

    Diabetes

    (2005)
  • G. Targher et al.

    Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients

    Diabetes Care

    (2007)
  • A. Simon et al.

    Coronary risk estimation and treatment of hypercholesterolemia

    Circulation

    (1997)
  • G. Heiss et al.

    Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study

    Am J Epidemiol

    (1991)
  • A. Simon et al.

    Intima-media thickness: a new tool for diagnosis and treatment of cardiovascular risk

    J Hypertens

    (2002)
  • D.F. Stroup et al.

    Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group

    JAMA

    (2000)
  • Cited by (0)

    This study was partially supported by grants UBACYT B119 (Universidad de Buenos Aires), PICT 05-25920 and PICT 2006-124 (Agencia Nacional de Promoción Científica y Tecnológica), PIP 5195 (Consejo Nacional de Investigaciones Científicas y Técnicas), Fundación Alfredo Lanari, and Consejo de Investigación de la Ciudad Autonóma de Bs.As. S.S., and C.J.P. belong to Consejo Nacional de Investigaciones Científicas. S.S. belongs to Consejo de Investigacion de la Ciudad de Buenos Aires. The authors declare that they do not have anything to disclose regarding funding from industries or conflict of interest with respect to this manuscript.

    View full text